The Authors' Reply: Obesity and Allometric Scaling of Pharmacokinetics

Author： Diepstraten Jeroen   Knibbe Catherijne A.J.  

Publisher： Adis International

ISSN： 0312-5963

Source： Clinical Pharmacokinetics, Vol.50, Iss.11, 2011-11, pp. : 755-756

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Obesity and Allometric Scaling of Pharmacokinetics

By Eleveld Douglas J.   Proost Johannes H.   Absalom Anthony R.   Struys Michel M.R.F.  

Clinical Pharmacokinetics, Vol. 50, Iss. 11, 2011-11 ,pp. : 751-753

Adis International

Access to resources Recommend Favorite

Allometric or Lean Body Mass Scaling of Propofol Pharmacokinetics: Towards Simplifying Parameter Sets for Target-Controlled Infusions

By >  

Clinical Pharmacokinetics, Vol. 51, Iss. 3, 2012-03 ,pp. : 137-145

Adis International

Access to resources Recommend Favorite

Mixed Effect Modeling of Sumatriptan Pharmacokinetics During Drug Development. I: Interspecies Allometric Scaling

By Cosson Valérie F.   Fuseau Eliane   Efthymiopoulos Constantin   Bye Alan  

Journal of Pharmacokinetics and Pharmacodynamics, Vol. 25, Iss. 2, 1997-04 ,pp. : 149-167

Springer Publishing Company

Access to resources Recommend Favorite

The Authors' Reply

By Stip Emmanuel   Moteshafi Hoda  

Drug Safety, Vol. 35, Iss. 12, 2012-12 ,pp. : 1183-1184

Adis International

Access to resources Recommend Favorite

The Authors' Reply

By Toovey Stephen  

Drug Safety, Vol. 35, Iss. 12, 2012-12 ,pp. : 1188-1190

Adis International

Access to resources Recommend Favorite